Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
The beginning of the end of cannabis prohibition
The federal government is moving toward “rescheduling” cannabis to recognize its medicinal use. That’s not far enough — but it’s a major step forward.
By Paul Armentano,
Guest Columnist
May 15, 2024
The federal government is moving toward “rescheduling” cannabis to recognize its medicinal use.
For the first time in its history, the Justice Department is calling for a change in the federal legal status of cannabis — which is currently classified as one of America’s most dangerous drugs.
The Attorney General’s office recently confirmed that it’s circulating a proposal to reclassify marijuana from Schedule I to Schedule III under the federal Controlled Substances Act. The move, which affirms a prior recommendation by the Department of Health and Human Services and the FDA, marks an about-face for bureaucracies that have traditionally maintained a “flat earth” perspective for all things cannabis.
Under federal guidelines, Schedule I substances possess “no currently accepted medical use in the United States” and “lack accepted safety for use under medical supervision.” By contrast, Schedule III substances, like ketamine and anabolic steroids, are recognized as having well-established medical use and an acceptable safety profile for patients.
The federal government’s decision to finally recognize cannabis as a legitimate therapeutic agent is historic.
For decades, federal officials maligned patients and doctors who spoke out about the benefits of cannabis. One former federal drug czar even accused physicians who supported medical marijuana of practicing “Cheech & Chong medicine.”
For years, the government actively campaigned against statewide medical cannabis legalization initiatives — and even went so far as to try and strip physicians of their medical licenses for daring to discuss cannabis therapy with the sick and dying.
Not anymore.
According to HHS, an estimated 30,000 health practitioners in the United States are currently authorizing medical marijuana for their patients. The department also acknowledged that “the vast majority of individuals who use marijuana are doing so in a manner that does not lead to dangerous outcomes to themselves or others.”
The government’s stunning reversal validates the experiences of tens of millions of Americans. But it still falls well short of the changes necessary to bring federal marijuana policy into the 21st century. Specifically, the proposed change fails to harmonize federal marijuana policy with the cannabis laws of most U.S. states, particularly the 24 states that have legalized its use and sale to adults.
These jurisdictions regulate marijuana in a manner far more akin to alcohol — a substance omitted from the Controlled Substances Act — than a prescription drug. As a result, the state-licensed adult-use cannabis industry — and those who patronize it — will continue to operate in legal limbo, without any clear guidance from the federal government.
Nevertheless, as a first step forward, this policy change dramatically shifts the political debate surrounding cannabis.
Specifically, it delegitimizes many of the tropes historically exploited by opponents of marijuana policy reform. Claims that cannabis poses unique harms to health, or that it’s not useful for treating chronic pain and other ailments, have now been rejected by the very federal agencies that formerly perpetuated them.
Going forward, these specious allegations should be absent from any serious conversations surrounding cannabis and how to best regulate its use.
Of course, the longstanding politicization of cannabis won’t go away overnight. For decades, marijuana’s critics have derided both the plant and its consumers. Some will no doubt continue to try and do so despite the federal government’s decision to change course. But their claims will increasingly fall upon deaf ears.
After nearly a century of cannabis criminalization, prohibition is coming to an end.
Paul Armentano is the Deputy Director for NORML, the National Organization for the Reform of Marijuana Laws. This op-ed was distributed by OtherWords.org.
So?...where are the fact checkers?
we're going to swallow a whole "X" post without chewing on it first?
There is no "incident report"...no cops? No hired security report?
Maybe they were from outer space...got wind that Zen had some good shit?
Pretend I'm from Missouri...
Pretend I was born, just not last night...
agreeable $$$$$ thanks
Yeah, been lurking here and decided to make an account today. Been holding my PVSP share for probably a year and a half now with no movement whatsoever, it's getting pretty frustrating lol.
Definitely not proactive more like reactive. Top notch security should have been top priority.
Congratz on joining ihub yesterday!! New job I see!!!
Zen
Why don't we ever get any updates from management? Just don't understand it's like they don't want the stock to run, but I guess it is a little difficult when there are 5 billion shares outstanding.
Only a dope would try to lol a 70mm share dump.
Zen
So the paid pumper agrees that 63 millions worth less than toilet tissues?
Lololo .. Zen .. to the moon!🤪
Must have some great security in place
White House Announces Cannabis Rescheduling
Iris Dorbian
Contributor
May 16, 2024,02:34pm EDT
White House announces cannabis rescheduling
In October 2022, President Biden requested federal agencies review reschedule cannabis. After an ... [+]GETTY
In an unprecedented but widely anticipated move made by a U.S. president, today Biden announced that his administration is rescheduling cannabis from Schedule I to Schedule III under the Controlled Substances Act. A 60-day public comment period will commence before this action is finalized and implemented.
The news was first reported by the Associated Press on April 30.
Currently, cannabis is categorized as a Schedule I substance, meaning it is criminally prohibited by federal law and has a "high potential for abuse." Rescheduling cannabis as a Schedule III substance means it is legal to posses in licensed pharmacies under a doctor's prescription. Examples of Schedule III drugs are anabolic steroids and ketamine.
For leading professionals and practitioners, the news is a major step in the history of the fragmented legal U.S. cannabis industry. Although it doesn't end prohibition and inequities still remain, rescheduling is yet another sign of the increasing mainstream acceptance of cannabis.
Brian Vicente, founder of Vicente LLP, a cannabis law firm, said rescheduling would greatly alleviate the herculean tax burden of many licensed cannabis businesses since they are currently selling a Schedule I substance.
"We work with hundreds of licensed cannabis businesses, and the ability to deduct ordinary operating costs under the Schedule III proposal would be a game-changer for them," explained Vicente. "This proposal will release cannabis businesses from the crippling tax burden they are currently shackled with and allow these businesses to grow and prosper.”
Emily Paxhia, a managing partner at cannabis-focused investment firm Poseidon Asset Management, also applauded this historic White House action particularly as it follows solid evidence that legalization and regulation at the state level do work. "The tired and fear-based tactics of the prohibitionists are thin and will not play well in a fight against this progress," said Paxhia. "The industry, the states, the HHS, and the medical community have data to show that reform has been productive. We will continue to work the process with pragmatism and facts until the final scheduling is achieved."
Wendy Bronfein, co-founder, chief brand officer and director of public policy at medical cannabis brand Curio Wellness, also expressed jubilation; however, she tempered her celebratory tone with caution, underscoring the ultimate goal—descheduling.
“The only way to eliminate stigma and legitimize the legal cannabis industry is to fully remove cannabis from the Controlled Substances Act,” stressed Bronfein. “For as long as cannabis is listed as a scheduled substance, there will always be an inherent conflict between federal and state law. We encourage the federal government to seek a balance between exercising federal oversight and enforcement responsibilities while preserving each state’s ability to determine the best approach to cannabis within its borders.”
Justice Department takes 'major step' toward rescheduling marijuana
In a video announcement Thursday, President Joe Biden said he is “committed to righting” the wrongs of a “failed approach to marijuana.”
Biden Administration takes steps to reclassify marijuana as lower-risk
May 16, 2024, 1:00 PM EDT / Updated May 16, 2024, 1:13 PM EDT
By Julie Tsirkin and Monica Alba
WASHINGTON — The Justice Department took a significant step toward rescheduling marijuana Thursday, formalizing its process to reclassify the drug as lower-risk and remove it from a category in which it has been treated as more dangerous than fentanyl and meth.
President Joe Biden announced the “major” move in a direct-to-camera video posted to his official account on X. “This is monumental,” Biden said in the message. “It’s an important move towards reversing long-standing inequities. … Far too many lives have been upended because of a failed approach to marijuana, and I’m committed to righting those wrongs. You have my word on it.”
The Biden administration has been signaling that it would move to reschedule the drug from Schedule I — a strict classification including drugs like heroin — to the less-stringent Schedule III, which would for the first time acknowledge the drug’s medical benefits at the federal level. The Drug Enforcement Administration submitted a notice of proposed rulemaking in the Federal Register on Thursday afternoon, triggering a 60-day comment period that will allow members of the public to submit remarks regarding the rescheduling proposal before it is finalized.
Biden first directed federal agencies to review how marijuana is scheduled in October 2022, weeks before that year’s midterm elections. The process was led by the DOJ and the Department of Health and Human Services.
“Look folks, no one should be in jail for merely using or possessing marijuana. Period,” Biden said in Thursday’s video, his third time speaking extensively on the topic since his directive two years ago.
The second time Biden addressed the issue was during this year’s State of the Union address, making history by referring to marijuana from the dais in the House chamber. “No one should be jailed for using or possessing marijuana,” he said at the time.
Vice President Kamala Harris also released a video Thursday, hailing the progress.
“Currently marijuana is classified on the same level as heroin and more dangerous than fentanyl. We are finally changing that,” Harris said. “We are on the road to getting it done.”
During the first 30 days of the comment period, interested parties could request a hearing regarding the rescheduling proposal. Under the statute, the DEA would be required to hold a hearing before an administrative law judge.
After the DEA reviews and considers the public comments, and at the conclusion of any requested hearing, the DEA will issue a final order to reschedule marijuana. (The DEA could decline to reschedule the drug but that’s unlikely given the administration’s strong support).
The entire process can take anywhere from a few months to up to a year.
Once completed, federal scientists will be able to research and study the potential medical benefits of the drug for the first time since the Controlled Substances Act was enacted in 1971. It could also open the door for pharmaceutical companies to get involved with the sale and distribution of medical marijuana in states where it is legal.
For the $34 billion cannabis industry, the move would also eliminate significant tax burdens for businesses in states where the drug is legal, notably removing it from the IRS code’s Section 280E, which prohibits legal cannabis companies from deducting what would otherwise be ordinary business expenses.
Joe Biden walking in the garden
President Joe Biden in the Rose Garden on Monday, May 13, 2024.Demetrius Freeman / The Washington Post via Getty Images
The Justice Department’s rescheduling decision could also help shrink the black market, which has thrived despite legalization in states like New York and California, and has undercut legal markets, which are fiercely regulated and highly taxed.
During his time in office, Biden issued pardons for prior federal offenses of simple possession of marijuana and issued a proclamation granting additional pardons for simple possession, attempted simple possession and use of the drug.
The White House has also urged governors to do the same in their states and some have heeded the call, including in Oregon and Massachusetts.
Wow $18,000 bucks, LOL, LOL, LOL
Wow, can you believe $18,000 traded, my god man that is nearly 100 shares of Apple !!!!!!
Oh the humanity of it, the sky is falling run for your life !!!!
What a bunch of Dopes we have here.
WOW 63 millions dumped today..
Need cash for salaries of Riss and Germany?
Why aren't they paid in weed?
Let me guess...
No insurance!🤣
it is true I talked to CEO ands that latter was signed by him.It happened.
papamurf is the biggest basher/ short of PVSP/ Artizen, LOL
Kind of strange that the biggest PVSP / Artizen hater on twitter would be the one to discover some letter with no dates and Artizen management has said nothing.
Has been bashing for years now, check his posts.
So, I read from a post on X that one of Artizen's grow facilities had been burglarized, this company has nothing but setbacks.
https://twitter.com/papamurf_1/status/1790477752837017848/photo/1
Honestly, Riss has made many of us some big bucks. He may not know how to grow an actual Co but he dies know how to make crap flow uphill, lolololol!!!
Zen
It looks like someone purposely hitting .0003 in tiny amounts to keep the price looking weak to try to induce sellers to grab the .0003’s…
could the kitty do a better job than riss ?
The response you received is irrelevant, just more BS!! If I remember correctly, NetCapital made a bundle off pvsp, so sure they are pals, lolololol!!!!!!
Riss is the CCO at Netcapital
He has done all their financials and got them listed on Nasdaq, been pals for many years.
where's the connection...if any?
He turned Here to Serve into a garage door sales and service...(small local SoCal)
Now he's a gold miner in Canada...
and...
Riss is setting up NetCapital for Broker-Dealer License !!!!!
Sure would be nice to have a friendly Broker - Dealer for small cap issuers, like Paul Riss Tweeted
Paul Riss
@PaulRiss
$NCPL expanding its ecosystem. Wouldn't it be nice to do 15c2-11 filings for small cap issuers?
https://twitter.com/PaulRiss
Yep, and others like it.zen
I posted this several months ago…
Flippers be flipping, not expecting a run until record date announcement of the spinoff…
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=173785221
So unless there’s news in the meantime that would dramatically affect the stock price to jump, I don’t see much happening while we wait…
Wow, we are getting hotter now....$225.00 total trading for a Monday.... Geez this Is Sad.... Nice Wall though...22Million on the ask... .0005. Cheap but very little market interest at the moment... Hope things can Change for the Positive...
$PVSP
In answer to some mail concerning PVSP...I've been sidetracked by the new puppy for one thing...the other thing is fishy...as in 3 day old fishy...I see who started it now and it explains a lot...I can't send private messages and am not about to give IH another 12 bucks a month! post it or suck it...one of the two?
I think NOLs come in play and we have mllions of those
Reclassifying Marijuana Could Unlock Billions in Tax Savings for Cannabis Companies
Wall Street Journal
Proposed change could lift income-tax burden that wipes out most licensed marijuana retailers’ earnings
By
Jennifer Maloney
May 5, 2024 9:00 am ET
Cannabis businesses are currently barred from claiming deductions on many basic business expenses.
Many U.S. cannabis businesses could become profitable for the first time if the Biden administration follows through on its plan to reclassify marijuana as a less dangerous drug.
That is because the change could lift a heavy income-tax burden: Section 280E of the federal tax code currently bars cannabis businesses from claiming deductions on many basic business expenses. That rule often results in an effective tax rate of 70% or more, wiping out most licensed marijuana retailers’ earnings.
“It’s an absolute game-changer,” said Boris Jordan, executive chairman of Curaleaf Holdings, which operates 145 dispensaries and 19 cultivation sites across the U.S. “It’s something we’ve been waiting for, for the better part of 10 years.”
The proposed rule could take months to complete and could be further stalled by lawsuits. The public, including state regulators and marijuana companies, would have a chance to comment and the White House would have to sign off on a final version of the rule before it could go into effect.
Marijuana is legal in some form in 40 states and the District of Columbia, but is illegal under federal law—and would remain so even if the Drug Enforcement Administration moved marijuana from Schedule I to the less-restrictive Schedule III, equivalent to prescription medications such as anabolic steroids and some combinations of acetaminophen and codeine.
Cannabis businesses would still have to contend with limited access to banking services and financing. They still wouldn’t be allowed to transport marijuana across state lines. And companies that sell marijuana in the U.S. still couldn’t be traded on U.S. stock exchanges. (Several Canadian operators are listed on U.S. exchanges while U.S. operators are listed on Canadian exchanges.)
Current tax rules allow cannabis businesses to deduct their cost of goods sold, so growers that put most of their resources into production don’t get hit hard.
A national survey conducted in 2022 by Whitney Economics, a cannabis industry research firm, found that fewer than 25% of cannabis businesses were profitable. Licensed U.S. cannabis companies this year are expected to make $31.4 billion in sales and pay $2.3 billion more in federal taxes than they would under normal business tax rules, according to Whitney Economics forecasts.
For companies that have been hanging on in hope of one day making it into the black, the policy change could be transformative. Business leaders said they could use the cash to invest more in marketing, offer better benefits to employees and expand into newly opened markets such as Ohio. Industry leaders said they are also optimistic that the policy shift could reduce the stigma around cannabis, bring more investors into the sector and make federal lawmakers more open to legalizing marijuana.
Congress created Section 280E of the tax code in 1982, when Sen. Bill Armstrong (R., Colo.) tucked the provision into a larger bill as the federal War on Drugs was ramping up.
Cresco Labs CEO Charlie Bachtell, center, said the company has paid millions more in U.S. federal taxes than it would have under normal business conditions. PHOTO: DANIEL ACKER/BLOOMBERG NEWS
The law denies many ordinary deductions and tax credits to businesses that are “trafficking in controlled substances” listed under Schedule I and II.
When marijuana was illegal at the federal and state levels, that deduction limit had a relatively small impact, and it mostly gave U.S. authorities an additional tool to go after drug dealers and impose taxes on top of criminal prosecutions. But state legalization combined with Section 280E created an odd hybrid. The cannabis industry looked like regular businesses in many respects—except for the income-tax bills.
“Draconian, I think, is putting it lightly,” said Charlie Bachtell, chief executive of Cresco Labs, which has dispensaries and production facilities across eight U.S. states. For each of the past two years, Cresco has paid between $70 million and $80 million more in U.S. federal taxes than it would have under normal business conditions, he said. Despite the hefty tax bill, Cresco in the last quarter of 2023 became free cash-flow positive for the first time since it went public in 2018.
The cannabis industry has “really been kind of stumbling its way forward because of the economic burdens of 280E,” said Brian Vicente, a cannabis lawyer in Denver.
The current tax rules allow cannabis businesses to deduct their cost of goods sold, so growers that put most of their resources into production don’t get hit hard. Businesses closer to the consumer get hammered by Section 280E. For instance, a retailer selling clothes or food can deduct rent, marketing and wages when calculating taxable income. But a cannabis retailer typically can’t take any of those deductions.
“It’s impossible to make those numbers work,” said Wanda James, CEO and co-founder of Simply Pure Brands, which has a dispensary in Colorado and a new branch about to open in New Jersey. “It’s just a question of how long is your runway.”
James, a former Navy officer, restaurateur and political organizer, was among the first Black cannabis licensees in Colorado. She said the tax change could lower the barriers to entry for women, people of color and veterans, many of whom have struggled to keep their cannabis businesses afloat after winning state lotteries for social-equity licenses.
The tax change could also shrink the gap in profitability between legal and illegal cannabis businesses, helping licensed businesses that have struggled to compete with the black market. Unlicensed operations can sell marijuana at lower prices and pay fewer administrative and regulatory costs.
More broadly, moving cannabis to Schedule III could create an unusual tax regime. Businesses would still face significant state taxes and high costs for banking and other services. But cannabis would actually have more favorable federal tax treatment than alcohol and tobacco, which are subject to federal excise taxes on top of income taxes.
You may have not seen this from the GERS board…
The alternative path to liquidity will likely take the form of a distribution or other transaction under which the Company’s common shareholders of record are issued shares in another publicly-traded company at a premium to the Company’s current market price, subject to fulfillment of the required conditions and the blessings of counsel for all applicable parties. That transaction is likely to involve a pre-existing equity interest in Artizen Corporation.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=165779947
Slashnuts
01/29/24 12:04 PM
Post #52,823
PVSP Get's 15% Of Artizen GERS Get's 16.15%...
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=171002918
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=171691384
[color=red][/color]
The change in ownership was a guesstimate ( thinking out loud )
Oldrogue.
A dreamer poster who thinks Gers is getting Artizen shares and controls pvsp.
Change in ownership!?
T+1...I heard that.
"Slashnuts"?...GERS...I will look...I would not put it past them to say "grab your ankles"!...
Do not like; Jonathan D. Leinwand...at all!
Refresh my memory...who's Slashnuts?
Thanks....
Over a billion accumulated…getting ready for something? Changing ownership?
I do know at the end of May 2024 most markets if not all go to a T+1 settlement date.
Slashnuts mentioned GERS stock holders would possibly get shares in PVSP. It’s just a wait and see?
Oldrogue.
100milly to UR...
Held at DTC Shares Updated:
🔴 2,944,228,659 (2024-03-28)
🟢 4,019,170,696 (2024-04-26)
Difference: +36.5% (+1.1B)
was done a week ago but just posted or no?
TIA...
Senators Schumer, Wyden and Booker reintroduce Cannabis legislation!!!
Good video of them announcing they are reintroducing the Cannabis Administration and Opportunity Act and striking while the iron is hot. They feel they have the wind at their backs on Cannabis legislation and are going full steam ahead!!!
We may have broken the log jamb and things are going to happen very quickly now on the way to legalization of cannabis.
May 1, 2024
On Wednesday, Majority Leader Chuck Schumer (D-NY), Sen. Ron Wyden (D-OR), and Sen. Cory Booker (D-NJ) held a press conference about the Cannabis Administration and Opportunity Act.
Ok Thanks Shaker777!!
Feel better now!! LOL
Thanks to everyone posting!! Hahah
Whenever I visit this board, I ignore all posts by BJones
I know they are irrelevant pumping posts, mostly a copy&paste of irrelevant interviews with the vampire.
But it was interesting today to see someone writes Thanks BJones
As it triggered a question: How many aliases BJones created to admire his deserted posts?
How about those New Artizen Hoodies & Tees !!
Look pretty Cool!
https://www.artizencannabis.com/shop
Pricella Ray has a bog on the New Site some good information on Cannabis.
https://www.artizencannabis.com/blogs
Majority Of Americans Say Marijuana Banking Bill Would Promote Public Safety And Help Underserved Communities,
Financial Association Poll Finds
Published on May 2, 2024By Kyle Jaeger
A strong majority of Americans agree that passing a marijuana banking bill would improve public safety, according to a new poll commissioned by Independent Community Bankers of America (ICBA).
The survey, conducted by Morning Consult, found that 64 percent of Americans feel the provisions of the Secure and Fair Enforcement Regulation (SAFER) Banking Act to allow cannabis businesses to access the banking system will “help improve public safety.”
A second question in the poll noted that some cannabis-related businesses are owned and led by people of color, women and members of the LGBTQ community, asking respondents whether “opening the banking system to cannabis-related businesses would help these underserved communities.” Fifty-four percent agreed.
CBD Can Help Treat Pain, Cancer, Schizophrenia, COVID And Other Conditions
As Senate leadership works to advance the legislation, which cleared committee last September, the ICBA poll that was released last week underscores that the proposal enjoys sizable public support.
ICBA has long advocated for the bipartisan cannabis banking legislation and commissioned several polls consistently demonstrating its popularity. The association’s president, Rebeca Romero Rainey, said in a press release that this latest survey featuring questions on cannabis banking and other policies of concern for the association shows that “Americans from coast to coast support our views on key policy issues.”
“With polling conducted by Morning Consult showing Americans understand the importance of these issues in ensuring continued access to locally based banking, ICBA is proud to continue helping community banks advocate in Washington and power the potential of local communities nationwide,” she said.
The polling is consistent with findings from a separate American Bankers Association (ABA) survey released last month that found 63 percent of Americans back cannabis businesses banking access, compared to just 17 percent who are opposed.
A prior ABA survey, in 2022, found 66 percent of people either strongly (37 percent) or somewhat (29 percent) supported marijuana banking reform, while 16 percent either strongly (8 percent) or somewhat (8 percent) opposed it. Nineteen percent of respondents last year said they didn’t know or didn’t have an opinion.
A separate ABA poll earlier in 2022 found that 68 percent of respondents felt Capitol Hill should act.
ICBA, meanwhile, also hosted a summit in Washington, D.C. this week, where House Financial Services Committee Chairman Vice Chair French Hill (R-AR) discussed ongoing bipartisan collaboration on a cryptocurrency regulations bill that certain lawmakers, including Senate Majority Leader Chuck Schumer (D-NY), hope will be merged with the SAFER Banking Act.
Hill said last week that he’d support a hybrid marijuana banking and cryptocurrency bill, saying “our country will benefit” if both reforms are enacted.
There have also been talks about attaching both measures to a must-pass Federal Aviation Administration (FAA) reauthorization bill. But those plans are meeting some opposition, with a Senate aide telling Marijuana Moment on Monday that Republican leadership is proactively opposing that possibility.
A spokesperson for Senate Minority Leader Mitch McConnell (R-KY) separately told Marijuana Moment that the senator, who is considered a legislative gatekeeper in the GOP caucus, “continues to oppose marijuana banking.” House Speaker Mike Johnson (R-LA) is also reportedly against the move to attach cannabis banking to the aviation legislation.
U.S. Senators Introduce Bill To Legalize Marijuana
A.J. Herrington
Contributor
I cover cannabis and hemp news, business, and culture.
May 2, 2024,09:33am EDT
A group of 18 Democratic Senators this week reintroduced a bill to legalize marijuana nationwide, only a day after news reports revealed that the U.S. government would reclassify cannabis under federal law. The legislation, known as the Cannabis Administration and Opportunity Act, was introduced in the Senate on Wednesday by Sen. Cory Booker of New Jersey, Senate Majority Chuck Schumer and Oregon’s Sen. Ron Wyden, with co-sponsorship by an additional 15 lawmakers in the upper chamber of Congress.
“It’s past time for the federal government to catch up to the attitudes of the American people when it comes to cannabis,” Schumer said in a statement about the bill. “That’s why we’re reintroducing the Cannabis Administration and Opportunity Act, legislation that would finally end the federal prohibition on cannabis while prioritizing safety, research, workers’ rights and restorative justice. We have more work to do to address decades of over-criminalization, particularly in communities of color, but today’s reintroduction shows the movement is growing, and I will keep working until we achieve meaningful change.”
The comprehensive legislation goes further that the Biden administration’s proposal to reclassify marijuana under the CSA that was advanced by the Department of Health and Human services last year. If approved by the White House Office of Management and Budget, the proposal would remove cannabis from Schedule I, the strictest classification that includes heroin and LSD, and instead place it under Schedule III, a group of drugs such as Tylenol with codeine and testosterone. I
n January, the U.S. Food and Drug Administration (FDA) determined that marijuana was eligible for reclassification after a review of relevant scientific data. On Tuesday, the Associated Press reported that the Drug Enforcement Administration had approved the bid to reschedule marijuana and ease restrictions on the drug under federal law.
“Our comprehensive Cannabis Administration and Opportunity Act doesn’t tell states what to do—but it provides them with the tools to effectively implement the laws their voters and legislators choose,” said Wyden. “Public health, public safety, opportunity and social justice must be at the core of any cannabis reform proposal, and it’s crucial stakeholders continue to have a seat at the table. I look forward to working with my colleagues and advocates across the country to make these priorities a reality.”
The comprehensive legislation goes further that the Biden administration’s proposal to reclassify marijuana under the CSA that was advanced by the Department of Health and Human services last year. If approved by the White House Office of Management and Budget, the proposal would remove cannabis from Schedule I, the strictest classification that includes heroin and LSD, and instead place it under Schedule III, a group of drugs such as Tylenol with codeine and testosterone. In January, the U.S. Food and Drug Administration (FDA) determined that marijuana was eligible for reclassification after a review of relevant scientific data. On Tuesday, the Associated Press reported that the Drug Enforcement Administration had approved the bid to reschedule marijuana and ease restrictions on the drug under federal law.
Looks like we have a NEW Website for Artizen?
Spin off must be getting close, new headquarters location and a New Website.
https://www.artizencannabis.com/
$PVSP Everything is falling in place! 😉https://t.co/QYYMUed2z7
— Pervasip Corp (@PervasipC) May 1, 2024
PVSP on X - "Everything is Falling into Place" !!!
Pervasip Corp
@PervasipC
·
$PVSP Everything is falling into place
https://twitter.com/search?q=%24PVSP&src=cashtag_click
Today the MJ Sector got Great Long Awaited News and Many Companies Enjoyed a Great Day in the Market. $PVSP traded less than 2,900.00$ Can Management Bring this Back to Life... .0004 is Rough...2 Billion Share Reduction would Help?? U Approved it 07/2022... @PervasipC https://t.co/I2N2vk9s9L pic.twitter.com/aubTq0s4zg
— Urocka (@UrockaLife) May 1, 2024
Followers
|
854
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
183754
|
Created
|
10/04/08
|
Type
|
Free
|
Moderators jobynimble DSherman allenc Urocka |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |